Literature DB >> 32295501

Associations between Psychiatric Disorders and Cannabis-Related Disorders Documented in Electronic Health Records.

Anne Campbell1, Steffani R Bailey2, Kim A Hoffman3, Javier Ponce-Terashima4, Katie Fankhauser2, Miguel Marino2,3, Dennis McCarty3.   

Abstract

Data from a large network of community health centers connected via a single electronic health record (EHR) system examined associations between psychiatric disorders and documentation of a cannabis-related disorder among patients with reported cannabis use. Participants were adults who had at least one ambulatory visit at a clinic in three states between 1/1/2012 and 12/31/2016 and had either 1) a documented cannabis-related disorder indicated by an ICD-9/10 code on the problem list or encounter list or 2) documentation of cannabis use in the EHR social history section. Clinics included 101,405 patients with either cannabis use recorded in the social history of the EHR (n = 71,660) or a cannabis-related disorder documented in the encounter or problem list (n = 29,745). GEE logistic regression modeling estimated adjusted odds ratios (aOR). Odds of patients having cannabis-related disorder recorded on the encounter or problem list were higher for individuals with depression (aOR = 1.08, 95% CI: 1.04-1.13), anxiety (aOR = 1.16, CI: 1.11-1.21) and bipolar disorder (aOR = 1.16, CI: 1.10-1.23). A diagnosis of schizophrenia increased the odds of a cannabis-related disorder by 62% (aOR = 1.62, CI: 1.48- 1.78). Primary care providers should routinely screen for and document cannabis-related disorders and psychiatric disorders.

Entities:  

Keywords:  Substance use disorder; cannabis use disorder; electronic health records; psychiatric disorders

Year:  2020        PMID: 32295501      PMCID: PMC7671705          DOI: 10.1080/02791072.2020.1747665

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  32 in total

1.  Changes in Cannabis Potency Over the Last 2 Decades (1995-2014): Analysis of Current Data in the United States.

Authors:  Mahmoud A ElSohly; Zlatko Mehmedic; Susan Foster; Chandrani Gon; Suman Chandra; James C Church
Journal:  Biol Psychiatry       Date:  2016-01-19       Impact factor: 13.382

2.  The association between cannabis use and mood disorders: A longitudinal study.

Authors:  Daniel Feingold; Mark Weiser; Jürgen Rehm; Shaul Lev-Ran
Journal:  J Affect Disord       Date:  2014-10-13       Impact factor: 4.839

Review 3.  Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.

Authors:  Kevin P Hill
Journal:  JAMA       Date:  2015 Jun 23-30       Impact factor: 56.272

Review 4.  Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.

Authors:  Penny F Whiting; Robert F Wolff; Sohan Deshpande; Marcello Di Nisio; Steven Duffy; Adrian V Hernandez; J Christiaan Keurentjes; Shona Lang; Kate Misso; Steve Ryder; Simone Schmidlkofer; Marie Westwood; Jos Kleijnen
Journal:  JAMA       Date:  2015 Jun 23-30       Impact factor: 56.272

5.  Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA).

Authors:  Femke Lamers; Patricia van Oppen; Hannie C Comijs; Johannes H Smit; Philip Spinhoven; Anton J L M van Balkom; Willem A Nolen; Frans G Zitman; Aartjan T F Beekman; Brenda W J H Penninx
Journal:  J Clin Psychiatry       Date:  2011-01-25       Impact factor: 4.384

6.  Cannabis use and mental health in young people: cohort study.

Authors:  George C Patton; Carolyn Coffey; John B Carlin; Louisa Degenhardt; Michael Lynskey; Wayne Hall
Journal:  BMJ       Date:  2002-11-23

7.  Cannabis use and psychosis: a longitudinal population-based study.

Authors:  J van Os; M Bak; M Hanssen; R V Bijl; R de Graaf; H Verdoux
Journal:  Am J Epidemiol       Date:  2002-08-15       Impact factor: 4.897

8.  A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population--a meta-analysis of 31 studies.

Authors:  Karina Karolina Kedzior; Lisa Tabata Laeber
Journal:  BMC Psychiatry       Date:  2014-05-10       Impact factor: 3.630

Review 9.  Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis.

Authors:  Arianna Marconi; Marta Di Forti; Cathryn M Lewis; Robin M Murray; Evangelos Vassos
Journal:  Schizophr Bull       Date:  2016-02-15       Impact factor: 9.306

10.  Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.

Authors:  Marta Di Forti; Hannah Sallis; Fabio Allegri; Antonella Trotta; Laura Ferraro; Simona A Stilo; Arianna Marconi; Caterina La Cascia; Tiago Reis Marques; Carmine Pariante; Paola Dazzan; Valeria Mondelli; Alessandra Paparelli; Anna Kolliakou; Diana Prata; Fiona Gaughran; Anthony S David; Craig Morgan; Daniel Stahl; Mizanur Khondoker; James H MacCabe; Robin M Murray
Journal:  Schizophr Bull       Date:  2013-12-17       Impact factor: 9.306

View more
  1 in total

1.  Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.

Authors:  Howard Padwa; David Huang; Larissa Mooney; Christine E Grella; Darren Urada; Douglas S Bell; Brittany Bass; Anne E Boustead
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-05-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.